A detailed history of Harbour Trust & Investment Management CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Harbour Trust & Investment Management CO holds 3,470 shares of GILD stock, worth $324,098. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,470
Previous 3,470 -0.0%
Holding current value
$324,098
Previous $238 Million 22.2%
% of portfolio
0.03%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$63.15 - $72.88 $19,260 - $22,228
-305 Reduced 8.08%
3,470 $238 Million
Q1 2024

Apr 22, 2024

BUY
$71.58 - $87.29 $21,831 - $26,623
305 Added 8.79%
3,775 $277 Million
Q4 2023

Jan 26, 2024

BUY
$73.27 - $83.09 $254,246 - $288,322
3,470 New
3,470 $281 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $117B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Harbour Trust & Investment Management CO Portfolio

Follow Harbour Trust & Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Trust & Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Harbour Trust & Investment Management CO with notifications on news.